Overview
SGRY market data
Price History
SGRY price chart · 1M
- O
- 13.96
- H
- 14.08
- L
- 13.68
- C
- 13.93
- Vol
- 111,014.00
- Source
- US equities market feed
- Observed
- Aug 27, 2026, 12:00 AM
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $13.96
- Previous Close
- $14.04
- Day High
- $14.08
- Day Low
- $13.68
- 52 Week High
- $17.40
- 52 Week Low
- $13.15
- 7 Day Return
- -0.04%
- 30 Day Return
- -10.56%
- 90 Day Return
- +4.19%
- 1 Year Return
- +0.40%
- Daily Notional Volume
- $1.5M Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$0.61 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.92 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -2.7% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $11.41 – $23.66 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $2B · P/B 1.17 · P/S 0.78.
Company News
TD Cowen Maintains Buy on Surgery Partners, Raises Price Target to $19Benzinga · Aug 11, 2026, 4:09 PM
RBC Capital Maintains Outperform on Surgery Partners, Lowers Price Target to $19Benzinga · Aug 11, 2026, 3:32 PM
Cantor Fitzgerald Reiterates Overweight on Surgery Partners, Maintains $18 Price TargetBenzinga · Aug 11, 2026, 12:02 PM
8-K filing — Surgery Partners, Inc. (SGRY)SEC EDGAR · Aug 10, 2026, 11:32 AM
Surgery Partners Q2 Adj. EPS $0.10 Beats $0.06 Estimate, Sales $848.900M Beat $830.366M EstimateBenzinga · Aug 10, 2026, 11:31 AM
Surgery Partners Affirms FY2026 Sales Guidance of $3.350B-$3.450B vs $3.408B EstBenzinga · Aug 10, 2026, 11:30 AM
Surgery Partners Monetizes Idaho Assets As It Chases Faster GrowthBenzinga · Jul 24, 2026, 4:56 PM
Surgery Partners To Sell Ownership Interests In Mountain View Hospital And Idaho Falls Community Hospital To Intermountain Health; Deal Values Combined Idaho Falls Facilities At ~$1.15B, Total Consideration To Surgery Partners ~$795MBenzinga · Jul 24, 2026, 1:02 PM
Shares of healthcare services companies are trading lower amid sympathy with HCA Healthcare after that company lowered its FY26 GAAP EPS guidance.Benzinga · Jul 14, 2026, 5:20 PM